Your browser doesn't support javascript.
loading
Large-cohort humanized NPI mice reconstituted with CD34+ hematopoietic stem cells are feasible for evaluating preclinical cancer immunotherapy.
Xu, Xiongfei; Gu, Haihui; Li, Hongwei; Gao, Suizhi; Shi, Xiaohan; Shen, Jing; Li, Bo; Wang, Huan; Zheng, Kailian; Shao, Zhuo; Cheng, Peng; Cha, Zhanshan; Peng, Siying; Nie, Yongzhan; Li, Zhaoshen; Guo, Shiwei; Qian, Baohua; Jin, Gang.
Afiliación
  • Xu X; Department of Hepatobiliary Pancreatic Surgery, Changhai Hospital, Naval Medical University, Shanghai, China.
  • Gu H; Shanghai Institute of Pancreatic Diseases, Changhai Hospital, Naval Medical University, Shanghai, China.
  • Li H; Department of Transfusion Medicine, Changhai Hospital, Naval Medical University, Shanghai, China.
  • Gao S; State Key Laboratory of Cancer Biology and National Clinical Research Center for Digestive Diseases, Xijing Hospital of Digestive Diseases, Air Force Military Medical University, Xi'an, China.
  • Shi X; Department of Hepatobiliary Pancreatic Surgery, Changhai Hospital, Naval Medical University, Shanghai, China.
  • Shen J; Department of Hepatobiliary Pancreatic Surgery, Changhai Hospital, Naval Medical University, Shanghai, China.
  • Li B; Department of Hepatobiliary Pancreatic Surgery, Changhai Hospital, Naval Medical University, Shanghai, China.
  • Wang H; Department of Hepatobiliary Pancreatic Surgery, Changhai Hospital, Naval Medical University, Shanghai, China.
  • Zheng K; Department of Hepatobiliary Pancreatic Surgery, Changhai Hospital, Naval Medical University, Shanghai, China.
  • Shao Z; Department of Hepatobiliary Pancreatic Surgery, Changhai Hospital, Naval Medical University, Shanghai, China.
  • Cheng P; Department of Hepatobiliary Pancreatic Surgery, Changhai Hospital, Naval Medical University, Shanghai, China.
  • Cha Z; Department of Hepatobiliary Pancreatic Surgery, Changhai Hospital, Naval Medical University, Shanghai, China.
  • Peng S; Department of Transfusion Medicine, Changhai Hospital, Naval Medical University, Shanghai, China.
  • Nie Y; BEIJING IDMO Co. Ltd., Beijing, China.
  • Li Z; State Key Laboratory of Cancer Biology and National Clinical Research Center for Digestive Diseases, Xijing Hospital of Digestive Diseases, Air Force Military Medical University, Xi'an, China.
  • Guo S; Shanghai Institute of Pancreatic Diseases, Changhai Hospital, Naval Medical University, Shanghai, China.
  • Qian B; Department of Gastroenterology, Changhai Hospital, Naval Medical University, Shanghai, China.
  • Jin G; Department of Hepatobiliary Pancreatic Surgery, Changhai Hospital, Naval Medical University, Shanghai, China.
FASEB J ; 36(4): e22244, 2022 04.
Article en En | MEDLINE | ID: mdl-35262964
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Anticuerpos Biespecíficos / Neoplasias Límite: Animals / Humans Idioma: En Revista: FASEB J Asunto de la revista: BIOLOGIA / FISIOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Anticuerpos Biespecíficos / Neoplasias Límite: Animals / Humans Idioma: En Revista: FASEB J Asunto de la revista: BIOLOGIA / FISIOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: China